University of Portsmouth: Setback in Gene Therapy for Duchenne Muscular Dystrophy as Immune System Emerges as Key Barrier
April 09, 2025
April 09, 2025
PORTSMOUTH, England, April 9 -- The University of Portsmouth issued the following news:
* * *
Setback in gene therapy for Duchenne muscular dystrophy as immune system emerges as key barrier
A major trial of a promising gene therapy for Duchenne muscular dystrophy has fallen short, but researchers say the lessons learned could pave the way for better, more effective treatments
* New research identifies the body's own immune response as a cr . . .
* * *
Setback in gene therapy for Duchenne muscular dystrophy as immune system emerges as key barrier
A major trial of a promising gene therapy for Duchenne muscular dystrophy has fallen short, but researchers say the lessons learned could pave the way for better, more effective treatments
* New research identifies the body's own immune response as a cr . . .